Tandem Diabetes Care (TNDM) Gross Margin Growth (3y) (2016 - 2026)
Tandem Diabetes Care (TNDM) Gross Margin Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.16 Bn | 176.87 Bn | 6.27 Bn | 63.00 |
| 2 | Stryker | 128.86 Bn | 125.98 Bn | 3.81 Bn | 17.00 |
| 3 | Medtronic | 108.89 Bn | 99.67 Bn | 6.41 Bn | 21.00 |
| 4 | Boston Scientific | 68.54 Bn | 67.08 Bn | 3.61 Bn | 15.00 |
| 5 | Edwards Lifesciences | 47.44 Bn | 43.76 Bn | 1.29 Bn | -324.00 |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.16 Bn | 1.98 Bn | -164.00 |
| 7 | Dexcom | 28.36 Bn | 27.24 Bn | 750.30 Mn | 56.00 |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 25.54 Bn | 22.42 Bn | 2.07 Bn | 311.00 |
| 10 | Tandem Diabetes Care | 1.14 Bn | 574.71 Mn | 136.79 Mn | 638.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 638.00 |
| Dec 31, 2025 | 528.00 |
| Sep 30, 2025 | 283.00 |
| Jun 30, 2025 | 139.00 |
| Mar 31, 2025 | -127.00 |
| Dec 31, 2024 | 155.00 |
| Sep 30, 2024 | -277.00 |
| Jun 30, 2024 | -288.00 |
| Mar 31, 2024 | -257.00 |
| Dec 31, 2023 | -647.00 |
| Sep 30, 2023 | -449.00 |
| Jun 30, 2023 | 214.00 |
| Mar 31, 2023 | -238.00 |
| Dec 31, 2022 | -321.00 |
| Sep 30, 2022 | -249.00 |
| Jun 30, 2022 | -261.00 |
| Mar 31, 2022 | 125.00 |
| Dec 31, 2021 | -35.00 |
| Sep 30, 2021 | 675.00 |
| Jun 30, 2021 | 950.00 |